Monte Rosa Therapeutics Inc (GLUE)

Cash & Short-Term Investments

$621.10M

Quarterly · Period ending: · USD

GLUE logo

GLUE Cash & Short-Term Investments

Latest reported$621.10M
GLUE Quarterly Cash & Short-Term Investments ($6.00M → $621.10M)
High-resolution chart · PNG

GLUE cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Monte Rosa Therapeutics Inc Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
621,104,000
666,220,000
377,104,000
391,258,000
290,594,000
326,074,000
372,149,000
242,186,000
262,205,000
192,892,000
232,413,000
178,477,000
203,066,000
231,734,000
262,826,000
272,149,000
294,145,000
317,163,000
346,071,000
367,034,000
357,060,000
168,436,000
41,699,000
5,995,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.